Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Revenue (2020 - 2025)

Celularity has reported Revenue over the past 6 years, most recently at $5.3 million for Q3 2025.

  • Quarterly results put Revenue at $5.3 million for Q3 2025, down 43.16% from a year ago — trailing twelve months through Sep 2025 was $23.1 million (down 52.0% YoY), and the annual figure for FY2024 was $54.2 million, up 138.11%.
  • Revenue for Q3 2025 was $5.3 million at Celularity, down from $5.7 million in the prior quarter.
  • Over the last five years, Revenue for CELU hit a ceiling of $14.7 million in Q1 2024 and a floor of $688000.0 in Q4 2024.
  • Median Revenue over the past 5 years was $4.9 million (2021), compared with a mean of $6.4 million.
  • Peak annual rise in Revenue hit 312.22% in 2024, while the deepest fall reached 94.32% in 2024.
  • Celularity's Revenue stood at $4.9 million in 2021, then decreased by 14.97% to $4.1 million in 2022, then skyrocketed by 193.34% to $12.1 million in 2023, then tumbled by 94.32% to $688000.0 in 2024, then surged by 668.02% to $5.3 million in 2025.
  • The last three reported values for Revenue were $5.3 million (Q3 2025), $5.7 million (Q2 2025), and $11.4 million (Q1 2025) per Business Quant data.